Skip to main content
Top
Published in: Esophagus 2/2016

01-04-2016 | Original Article

Clinical experience with four cases of jackhammer esophagus

Authors: Rui Nakato, Noriaki Manabe, Naoshi Mitsuoka, Hironari Shiwaku, Hideo Matsumoto, Kanefumi Yamashita, Akiko Shiotani, Jiro Hata, Tetsuo Watanabe, Toshihiro Hirai, Ken Haruma

Published in: Esophagus | Issue 2/2016

Login to get access

Abstract

Background

Although jackhammer esophagus (JE) requires proper treatment, many aspects of its clinical course remain unknown.

Method

The 4 cases were in patients diagnosed with JE among the 447 patients who underwent high-resolution manometry (HRM) at our hospital between January 2009 and October 2014, and we assessed the patients’ background, their HRM, gastrointestinal endoscopy, and contrast esophagography findings, whether they had esophageal muscle thickening, and their clinical course.

Result

All 4 cases were treated for proton pump inhibitor–resistance nonerosive reflux disease, and all of them were ultimately diagnosed as JE. The test findings revealed an esophageal hiatal hernia and esophageal muscle thickening in every case, contrast esophagography showed abnormal contractions in 3/4 cases. During a mean follow-up period of 3.3 years, progression from nutcracker esophagus [NE; the Chicago Classification (2012 version)] to JE was observed during the course of 2 of the 4 patients. In 1 of the 4 patients, the symptoms improved in the absence of treatment. Among the 3 patients who received treatment, the symptoms of 2 patients were controlled within tolerable intensity by conservative treatment, but surgical treatment was selected in the other case. However, because the symptoms recurred after the operation, peroral endoscopic myotomy was performed in addition.

Conclusions

Because the pathology at the onset and clinical course of JE are not uniform, it is necessary to tailor treatment policy to each individual case and to consider altering treatment policy according to the patient’s clinical course.
Literature
1.
go back to reference Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago classification of esophageal motor function disorders, v3.0. Neurogastroenterol Motil. 2015;27:160–74.CrossRefPubMed Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago classification of esophageal motor function disorders, v3.0. Neurogastroenterol Motil. 2015;27:160–74.CrossRefPubMed
2.
go back to reference Melchior C, Chiavelli H, Leroi AM, et al. Recovery of a “jackhammer esophagus” after the treatment of an eosinophilic esophagitis. Am J Gastroenterol. 2012;107:952–4.CrossRefPubMed Melchior C, Chiavelli H, Leroi AM, et al. Recovery of a “jackhammer esophagus” after the treatment of an eosinophilic esophagitis. Am J Gastroenterol. 2012;107:952–4.CrossRefPubMed
3.
go back to reference Hoshino M, Omura N, Yano F, et al. A case report of jackhammer esophagus. Nihon Shokaki Gakkai Zasshi. 2013;110:2107–11 (in Japanese). Hoshino M, Omura N, Yano F, et al. A case report of jackhammer esophagus. Nihon Shokaki Gakkai Zasshi. 2013;110:2107–11 (in Japanese).
4.
go back to reference Khan MQ, Nizami IY, Khan BJ, et al. Lung transplantation triggered “jackhammer esophagus”: a case report and review of literature. J Neurogastroenterol Motil. 2013;19:390–4.CrossRefPubMedPubMedCentral Khan MQ, Nizami IY, Khan BJ, et al. Lung transplantation triggered “jackhammer esophagus”: a case report and review of literature. J Neurogastroenterol Motil. 2013;19:390–4.CrossRefPubMedPubMedCentral
5.
go back to reference Weon JK, Byoung ML, Won YP, et al. Jackhammer esophagus treated by a preoral endoscopic myotomy. Korean J Gastroenterol. 2014;64:370–4.CrossRef Weon JK, Byoung ML, Won YP, et al. Jackhammer esophagus treated by a preoral endoscopic myotomy. Korean J Gastroenterol. 2014;64:370–4.CrossRef
6.
go back to reference Kandulski A, Fuchs KH, Weiqt J, et al. Jackhammer esophagus: high-resolution manometry and therapeutic approach using peroral endoscopic myotomy (POEM). Dis Esophagus. 2014 [Epub ahead of print]. Kandulski A, Fuchs KH, Weiqt J, et al. Jackhammer esophagus: high-resolution manometry and therapeutic approach using peroral endoscopic myotomy (POEM). Dis Esophagus. 2014 [Epub ahead of print].
7.
go back to reference Nomura T, Iwakiri K, Uchida E. Thoracoscopic treatment of a patient with jackhammer esophagus. Dig Endosc. 2014;26:753–4.CrossRefPubMed Nomura T, Iwakiri K, Uchida E. Thoracoscopic treatment of a patient with jackhammer esophagus. Dig Endosc. 2014;26:753–4.CrossRefPubMed
8.
go back to reference García-Lledó J, Clemente-Sánchez A, Merino-Rodríguez B, et al. Hypercontractile “Jackmammer esophagus”. Rev Esp Enferm Dig. 2015;107:204. García-Lledó J, Clemente-Sánchez A, Merino-Rodríguez B, et al. Hypercontractile “Jackmammer esophagus”. Rev Esp Enferm Dig. 2015;107:204.
9.
go back to reference Tsutsui H, Manabe N, Haruma K, et al. Esophageal motor dysfunction plays a key role in GERD with globus sensation—analysis of factors promoting resistance to PPI therapy. Scand J Gastroenterol. 2012;47:893–9.CrossRefPubMed Tsutsui H, Manabe N, Haruma K, et al. Esophageal motor dysfunction plays a key role in GERD with globus sensation—analysis of factors promoting resistance to PPI therapy. Scand J Gastroenterol. 2012;47:893–9.CrossRefPubMed
10.
go back to reference Hill LD, Kozarek RA, Kraemer SJ, et al. The gastroesophageal flap valve: in vitro and in vivo observations. Gastrointest Endosc. 1996;44:541–7.CrossRefPubMed Hill LD, Kozarek RA, Kraemer SJ, et al. The gastroesophageal flap valve: in vitro and in vivo observations. Gastrointest Endosc. 1996;44:541–7.CrossRefPubMed
11.
go back to reference Hongo M. Minimal changes in reflux esophagitis: red ones and white ones. J Gastroenterol. 2006;41:95–9.CrossRefPubMed Hongo M. Minimal changes in reflux esophagitis: red ones and white ones. J Gastroenterol. 2006;41:95–9.CrossRefPubMed
12.
go back to reference Manabe N, Haruma K, Hata J, et al. Evaluation of esophageal motility by endosonography using a miniature ultrasonographic probe in patients with reflux esophagitis. Scand J Gastroenterol. 2002;37:674–8.CrossRefPubMed Manabe N, Haruma K, Hata J, et al. Evaluation of esophageal motility by endosonography using a miniature ultrasonographic probe in patients with reflux esophagitis. Scand J Gastroenterol. 2002;37:674–8.CrossRefPubMed
13.
go back to reference Kuribayashi S, Iwakiri K, Kawada A, et al. Variant parameter values—as defined by the Chicago Criteria—produced by ManoScan and a new system with Unisensor catheter. Naurogastroenterol Motil. 2015;27:188–94.CrossRef Kuribayashi S, Iwakiri K, Kawada A, et al. Variant parameter values—as defined by the Chicago Criteria—produced by ManoScan and a new system with Unisensor catheter. Naurogastroenterol Motil. 2015;27:188–94.CrossRef
14.
go back to reference Bredenoord AJ, Fox M, Kahrilas PJ, et al. Chicago classification criteria of esophageal motor function disorders defined in high resolution esophageal pressure topography (EPT). Neurogastroenterol Motili. 2012;24:57–65.CrossRef Bredenoord AJ, Fox M, Kahrilas PJ, et al. Chicago classification criteria of esophageal motor function disorders defined in high resolution esophageal pressure topography (EPT). Neurogastroenterol Motili. 2012;24:57–65.CrossRef
16.
go back to reference Dogan I, Puckett JL, Bhalla V, et al. Prevalence of increased esophageal muscle thickness in patients with esophageal symptoms. Am J Gastroenterol. 2007;102:137–45.CrossRefPubMed Dogan I, Puckett JL, Bhalla V, et al. Prevalence of increased esophageal muscle thickness in patients with esophageal symptoms. Am J Gastroenterol. 2007;102:137–45.CrossRefPubMed
17.
go back to reference Louis H, Covas A, Coppens E, et al. Distal esophageal spasm treated by preoral endoscopic myotomy. Am J Gastroenterol. 2012;107:1926–7.CrossRefPubMed Louis H, Covas A, Coppens E, et al. Distal esophageal spasm treated by preoral endoscopic myotomy. Am J Gastroenterol. 2012;107:1926–7.CrossRefPubMed
18.
go back to reference Krishnan K, Lin CY, Keswani R, et al. Endoscopic ultrasound as an adjunctive evaluation in patients with esophageal motor disorders subtyped by high-resolution manometry. Neurogastroenterol Motil. 2014;26:1172–8.CrossRefPubMedPubMedCentral Krishnan K, Lin CY, Keswani R, et al. Endoscopic ultrasound as an adjunctive evaluation in patients with esophageal motor disorders subtyped by high-resolution manometry. Neurogastroenterol Motil. 2014;26:1172–8.CrossRefPubMedPubMedCentral
19.
go back to reference Song CW, Lee SJ, Jeen YT, et al. Inconsistent association of esophageal symptoms, psychometric abnormalities and dysmotility. Am J Gastroenterol. 2001;96:2312–6.CrossRefPubMed Song CW, Lee SJ, Jeen YT, et al. Inconsistent association of esophageal symptoms, psychometric abnormalities and dysmotility. Am J Gastroenterol. 2001;96:2312–6.CrossRefPubMed
20.
go back to reference Storr M, Allescher HD, Rosch T, et al. Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: a prospective study with long-term follow-up. Gastrointest Endosc. 2001;54:754–9.CrossRefPubMed Storr M, Allescher HD, Rosch T, et al. Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: a prospective study with long-term follow-up. Gastrointest Endosc. 2001;54:754–9.CrossRefPubMed
21.
go back to reference Marjoux S, Brochard C, Roman S, et al. Botulinum toxin injection for hypercontractile or spastic esophagueal motility disorders : may high-resolution manometry help to select cases? Dis Esophagus. 2014, [Epub ahead of print]. Marjoux S, Brochard C, Roman S, et al. Botulinum toxin injection for hypercontractile or spastic esophagueal motility disorders : may high-resolution manometry help to select cases? Dis Esophagus. 2014, [Epub ahead of print].
22.
go back to reference Nishikawa T, Yoshimura H, Imoto I, et al. A clinical study of efficacy for suppression of peristaltic motion with Shakuyaku-kanzoh-to (Tsumura No.68) and peppermint oil for barium enema. Gastroenterol Mass Surv. 2003;41(2):170–6 (in Japanese). Nishikawa T, Yoshimura H, Imoto I, et al. A clinical study of efficacy for suppression of peristaltic motion with Shakuyaku-kanzoh-to (Tsumura No.68) and peppermint oil for barium enema. Gastroenterol Mass Surv. 2003;41(2):170–6 (in Japanese).
23.
go back to reference Maeda T, Shinozuka K, Baba K, et al. Effect of shakuyaku-kanzoh-toh, a prescription composed of shakuyaku (Paeoniae Radix) and kanzoh (Glycyrrhizae Radix) on guinea pig ileum. J Pharmacobiodyn. 1983;6:153–60.CrossRefPubMed Maeda T, Shinozuka K, Baba K, et al. Effect of shakuyaku-kanzoh-toh, a prescription composed of shakuyaku (Paeoniae Radix) and kanzoh (Glycyrrhizae Radix) on guinea pig ileum. J Pharmacobiodyn. 1983;6:153–60.CrossRefPubMed
24.
go back to reference Sakai Y, Tsuyuguchi T, Ishihara T, et al. Confirmation of the antispasmodic effect of shakuyaku- kanzo-to (TJ-68), a Chinese herbal medicine, on the duodenal wall by direct spraying during endoscopic retrograde cholangiopancreatography. J Nat Med. 2009;63:200–3.CrossRefPubMed Sakai Y, Tsuyuguchi T, Ishihara T, et al. Confirmation of the antispasmodic effect of shakuyaku- kanzo-to (TJ-68), a Chinese herbal medicine, on the duodenal wall by direct spraying during endoscopic retrograde cholangiopancreatography. J Nat Med. 2009;63:200–3.CrossRefPubMed
25.
go back to reference Kusano M, Kuribayashi S, Hosaka H, et al. Gastrointestinal motility and Kanpo medicine. Nihon Shokakibyo Gakkai Zasshi. 2010;107:1592–603 (in Japanese).PubMed Kusano M, Kuribayashi S, Hosaka H, et al. Gastrointestinal motility and Kanpo medicine. Nihon Shokakibyo Gakkai Zasshi. 2010;107:1592–603 (in Japanese).PubMed
Metadata
Title
Clinical experience with four cases of jackhammer esophagus
Authors
Rui Nakato
Noriaki Manabe
Naoshi Mitsuoka
Hironari Shiwaku
Hideo Matsumoto
Kanefumi Yamashita
Akiko Shiotani
Jiro Hata
Tetsuo Watanabe
Toshihiro Hirai
Ken Haruma
Publication date
01-04-2016
Publisher
Springer Japan
Published in
Esophagus / Issue 2/2016
Print ISSN: 1612-9059
Electronic ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-015-0518-0

Other articles of this Issue 2/2016

Esophagus 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine